Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Thomas P. Lynch currently holds 600 shares of Orexigen Therapeutics, Inc. (OREX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas P. Lynch has been a net buyer of OREX stock. They have purchased $6.0K and sold $0 worth of shares.
Thomas P. Lynch's most recent insider trade was on Nov 7, 2025, when they sold 600 shares at $0.00 per share.
Thomas P. Lynch serves as Executive at Orexigen Therapeutics, Inc. (OREX). They have executed 4 insider transactions totaling $6.0K over their tenure at the company.
Thomas P. Lynch holds the position of Executive at Orexigen Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Thomas P. Lynch has shown a buying trading pattern, with $6.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Thomas P. Lynch was on Nov 7, 2025, when they purchased $6.0K worth of BLLN shares. This transaction involved 100 shares at $60.00 per share.
Thomas P. Lynch currently owns 600 shares of Orexigen Therapeutics, Inc. (OREX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Thomas P. Lynch's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Thomas P. Lynch has 4 Form 4 filings on record as an insider at Orexigen Therapeutics, Inc..
Set alerts for Thomas P. Lynch and 40,000+ other insiders.